Gefitinib or Carboplatin–Paclitaxel in Pulmonary AdenocarcinomaTony Mok, Masahiro Fukuoka, Yukito Ichinose et al.|New England Journal of Medicine|2009Cited by 8.2k
Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trialEdward S. Kim, Jean‐Yves Douillard, Vera Hirsh et al.|The Lancet|2008Cited by 1.2k
Molecular Predictors of Outcome With Gefitinib in a Phase III Placebo-Controlled Study in Advanced Non–Small-Cell Lung CancerFred R. Hirsch, Brian R. Holloway, Marileila Varella‐Garcia et al.|Journal of Clinical Oncology|2006Cited by 702
Interstitial Lung Disease in Japanese Patients with Lung CancerShoji Kudoh, Fredrik Nyberg, Harubumi Kato et al.|American Journal of Respiratory and Critical Care Medicine|2008Cited by 488